ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,879.81
0.13%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Concert Pharmaceuticals Inc (CNCE)

  7. Concert Pharmaceuticals Inc (CNCE) Noticias

CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CNCE
FechaHoraFuenteTítuloSímboloCompañía
16/03/202308:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202305:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202310:58Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202310:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202308:47Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202308:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202308:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
15/02/202306:00Business WireConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202316:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
13/02/202308:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/02/202307:12Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/02/202306:32Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CNCEConcert Pharmaceuticals Inc
01/02/202316:13Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202309:40Dow Jones NewsConcert Pharmaceuticals Shares Rally on Takeover by SunNASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202307:47Dow Jones NewsSun Pharmaceutical to Buy Concert Pharmaceuticals For Initial $576 MillionNASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202307:00Business WireSun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
09/12/202217:25TipRanksJonesTrading Keeps Their Buy Rating on Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
22/11/202205:25TipRanksH.C. Wainwright Remains a Buy on Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
21/11/202206:00Business WireConcert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair ResearchNASDAQ:CNCEConcert Pharmaceuticals Inc
09/11/202206:00Business WireConcert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
08/11/202205:25TipRanksConcert Pharma (CNCE) Gets a Buy from H.C. WainwrightNASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202221:25TipRanksConcert Pharma (CNCE) Receives a Buy from JonesTradingNASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202211:05TipRanksConcert Pharma (CNCE) Gets a Buy from JMP SecuritiesNASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202206:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202206:00Business WireConcert Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
31/10/202206:00Business WireConcert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022NASDAQ:CNCEConcert Pharmaceuticals Inc
12/09/202220:05TipRanksJonesTrading Sticks to Their Buy Rating for Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
10/09/202204:30Business WireConcert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV CongressNASDAQ:CNCEConcert Pharmaceuticals Inc
06/09/202206:00Business WireConcert Pharmaceuticals to Present at H.C. Wainwright Global Investment ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
01/09/202206:00Business WireBridges and Landmarks Across the USA Will Illuminate Blue Throughout the Month of September for Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE

Su Consulta Reciente

CCOM
US30
US 30
CCOM
SILVER
SILVER
USI
USTECH100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
CCOM
US500
US 500
NYSE
DIS
Walt Disney
NYSE
CVX
Chevron
PM
XAUUSD
Gold vs US Dollar
FX
USDMXN
US Dollar vs MXN
NYSE
AXP
American Express
NYSE
JPM
JP Morgan Chase
AMEX
XLV
Health Care Select Sector
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados